# PureCycle Technologies, Inc.: overview

PCT · Nasdaq · CIK 1830033 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pct.md) · [Financials](/companies/pct/financials.md) · [Filings](/companies/pct/filings.md) · [Insiders](/companies/pct/insiders.md)

Latest reported revenue: [$4.5m](/filings/0001830033-26-000026.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001830033-26-000026).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001193125-25-269651.md) | [0.0 d](/filings/0001193125-26-076801.md) | [1.6](/filings/0001830033-26-000014.md) | [1.7](/filings/0001830033-26-000026.md) | [2.4](/filings/0001193125-25-269651.md) | [2.7 d](/filings/0001193125-26-076801.md) | [4.1](/filings/0001830033-26-000014.md) | [4.5](/filings/0001830033-26-000026.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | [(2387.4%)](/filings/0001830033-26-000014.md) | [(2763.5%)](/filings/0001830033-26-000026.md) | [(1602.2%)](/filings/0001193125-25-269651.md) | [(2196.1%) d](/filings/0001193125-26-076801.md) | [(1012.7%)](/filings/0001830033-26-000014.md) | [(916.1%)](/filings/0001830033-26-000026.md) |
| Net margin | % | not reported | not reported | [559.0%](/filings/0001830033-26-000026.md) | [(8741.8%)](/filings/0001830033-26-000026.md) | [(1167.5%)](/filings/0001193125-25-269651.md) | [(697.1%) d](/filings/0001193125-26-076801.md) | [(810.3%)](/filings/0001830033-26-000026.md) | [(3152.0%)](/filings/0001830033-26-000026.md) |
| Diluted EPS | $ per share | [(0.54)](/filings/0001193125-25-269651.md) | not reported | [0.05](/filings/0001830033-26-000014.md) | [(0.81)](/filings/0001830033-26-000026.md) | [(0.31)](/filings/0001193125-25-269651.md) | not reported | [(0.21)](/filings/0001830033-26-000014.md) | [(0.80)](/filings/0001830033-26-000026.md) |
| Free cash flow | $m | [(42.6) d](/filings/0001193125-25-269651.md) | [(53.4) d](/filings/0001193125-26-076801.md) | [(53.9)](/filings/0001830033-26-000014.md) | [(45.3) d](/filings/0001830033-26-000026.md) | [(42.4) d](/filings/0001193125-25-269651.md) | [(42.0) d](/filings/0001193125-26-076801.md) | [(46.1)](/filings/0001830033-26-000014.md) | [(81.8) d](/filings/0001830033-26-000026.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [0.0](/filings/0001193125-26-076801.md) | [0.0](/filings/0001193125-26-076801.md) | [8.4](/filings/0001193125-26-076801.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | [(2171.6%)](/filings/0001193125-26-076801.md) |
| Net margin | % | not reported | not reported | not reported | not reported | [(2185.1%)](/filings/0001193125-26-076801.md) |
| Diluted EPS | $ per share | [(0.79)](/filings/0001830033-24-000029.md) | [(0.55)](/filings/0000950170-25-028422.md) | [(0.63)](/filings/0001193125-26-076801.md) | [(1.75)](/filings/0001193125-26-076801.md) | [(1.21)](/filings/0001193125-26-076801.md) |
| Free cash flow | $m | [(192)](/filings/0001830033-24-000029.md) | [(353)](/filings/0000950170-25-028422.md) | [(249)](/filings/0001193125-26-076801.md) | [(200)](/filings/0001193125-26-076801.md) | [(184)](/filings/0001193125-26-076801.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pct/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [SYLEBRA CAPITAL LLC](/funds/2003074.md) | 2026-06-30 | $276.4m | 34,077,574 |  | Unchanged |
| [Abundance Wealth Counselors](/funds/1767080.md) | 2026-06-30 | $205.3m | 25,312,529 |  | Added +16,776,002 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $90.0m | 11,102,761 |  | Added +1,378,941 |
| [LONGVIEW ASSET MANAGEMENT, LLC](/funds/1086477.md) | 2026-06-30 | $78.8m | 9,716,394 |  | Unchanged |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $64.4m | 7,936,333 |  | Added +921,873 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $60.9m | 7,513,543 |  | Added +548,078 |
| [Alyeska Investment Group, L.P.](/funds/1453072.md) | 2026-06-30 | $46.3m | 5,708,362 |  | New +5,708,362 |
| [Rokos Capital Management LLP](/funds/1666335.md) | 2026-06-30 | $40.0m | 4,927,873 |  | Added +3,479,089 |
| [Shay Capital LLC](/funds/1723643.md) | 2026-06-30 | $37.6m | 4,641,331 |  | Added +772,216 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $33.3m | 4,102,500 | Call | Added +1,158,200 |

## Recent filings

[All 513 filings](/companies/pct/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-31 | 16:15 ET | [8-K](/filings/0001830033-26-000029.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001830033-26-000029 |
| 2026-08-06 | 16:10 ET | [10-Q](/filings/0001830033-26-000026.md) | Quarterly report, period 2026-06-30 | 0001830033-26-000026 |
| 2026-08-06 | 16:05 ET | [8-K](/filings/0001830033-26-000025.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001830033-26-000025 |
| 2026-06-15 | 17:23 ET | [8-K](/filings/0001193125-26-271316.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-271316 |
| 2026-06-12 | 17:21 ET | [SCHEDULE 13D/A](/filings/0001085146-26-000446.md) | Ownership report, active investor, amended | 0001085146-26-000446 |
| 2026-06-11 | 21:27 ET | [8-K](/filings/0001193125-26-266413.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-266413 |
| 2026-05-11 | 08:30 ET | [8-K](/filings/0001830033-26-000017.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001830033-26-000017 |
| 2026-05-06 | 16:08 ET | [10-Q](/filings/0001830033-26-000014.md) | Quarterly report, period 2026-03-31 | 0001830033-26-000014 |
| 2026-05-06 | 16:06 ET | [8-K](/filings/0001830033-26-000013.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001830033-26-000013 |
| 2026-04-17 | 08:30 ET | [8-K](/filings/0001830033-26-000007.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001830033-26-000007 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-076801.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b33215d6-3c53-4b77-9968-cce9cd3c9e48)

## About the filer

- CIK: 1830033
- Tickers: PCT, PCTBP, PCTTU, PCTTW
- Exchange: Nasdaq
- SIC code: 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers
- State of incorporation: X1
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.